Overweight and obesity are not associated with worse clinical outcomes in COVID-19 patients treated with fixed-dose 6 mg dexamethasone.

Esther WittermansJan C GruttersHazra S MoeniralamGurbey OcakG Paul VoornWillem Jan W BosEwoudt M W van de Garde

Published in: International journal of obesity (2005) (2022)

Overweight and obesity are not associated with an unfavourable clinical course in COVID-19 patients admitted to a non-ICU ward and treated with 6 mg dexamethasone once daily.

Keyphrases

coronavirus disease
sars cov
high dose
low dose
intensive care unit
respiratory syndrome coronavirus
physical activity